Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
Si-Jun-Zi-Tang potentiates temozolomide's anti-melanoma efficacy and reduces its hepatotoxicity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Amy Sze Man, Wang Li, Fan Xiao-Yun, Wang Xiao-Qi, Wu Ying, Wu Jia-Ying, Bai Jing-Xuan, Han Rui-Xuan, He Jin-Jin, Fu Xiu-Qiong, Yu Zhi-Ling
Аннотация
BACKGROUND: Malignant melanoma remains a major challenge in oncology, largely due to the limited efficacy and significant toxicity associated with treatments such as temozolomide (TMZ). Si-Jun-Zi-Tang (SJZT), a traditional Chinese medicine formula with documented anti-cancer properties, has shown potential in enhancing chemotherapy effectiveness and reducing treatment-related toxicity.
PURPOSE: This study investigated the role of SJZT in improving TMZ treatment outcomes in melanoma.
METHODS: The effects of SJZT on TMZ treatment outcomes were evaluated in melanoma cell lines and mouse models. Cell proliferation, apoptosis, DNA damage, and cell cycle distribution were assessed using CCK-8 assays, Annexin V/PI staining, γ-H2AX immunofluorescence, and flow cytometry, respectively. In vivo antitumor efficacy and hepatotoxicity were evaluated in melanoma-bearing mice. Mechanistic insights were explored via network pharmacology and RNA sequencing, and validated by RT-qPCR, Western blotting, and rescue experiments.
RESULTS: SJZT enhanced TMZ-induced inhibition of cell proliferation, apoptosis, and DNA strand breaks in melanoma cells. SJZT also attenuated TMZ-induced G2/M arrest, promoting mitotic catastrophe. In mouse models, SJZT enhanced the anti-tumor effects of TMZ and mitigated TMZ-induced hepatotoxicity. Mechanistically, network pharmacology and experimental validation revealed that simultaneous inhibition of Chk1 and promotion of MGMT proteasomal degradation mediated the enhanced anti-melanoma effects of TMZ with SJZT. RNA sequencing and experimental validation demonstrated that TMZ upregulated the bile salt transporter Slc10a1/Ntcp and downregulated detoxifying enzymes Ugt1a1 and Slco1b2/Oatp2, disrupting bile acid homeostasis. Notably, SJZT co-administration reversed these changes, restoring bile acid balance.
CONCLUSION: These findings reveal that SJZT can enhance TMZ's therapeutic efficacy while reducing hepatotoxicity, supporting its use as a promising adjuvant in melanoma treatment.
PURPOSE: This study investigated the role of SJZT in improving TMZ treatment outcomes in melanoma.
METHODS: The effects of SJZT on TMZ treatment outcomes were evaluated in melanoma cell lines and mouse models. Cell proliferation, apoptosis, DNA damage, and cell cycle distribution were assessed using CCK-8 assays, Annexin V/PI staining, γ-H2AX immunofluorescence, and flow cytometry, respectively. In vivo antitumor efficacy and hepatotoxicity were evaluated in melanoma-bearing mice. Mechanistic insights were explored via network pharmacology and RNA sequencing, and validated by RT-qPCR, Western blotting, and rescue experiments.
RESULTS: SJZT enhanced TMZ-induced inhibition of cell proliferation, apoptosis, and DNA strand breaks in melanoma cells. SJZT also attenuated TMZ-induced G2/M arrest, promoting mitotic catastrophe. In mouse models, SJZT enhanced the anti-tumor effects of TMZ and mitigated TMZ-induced hepatotoxicity. Mechanistically, network pharmacology and experimental validation revealed that simultaneous inhibition of Chk1 and promotion of MGMT proteasomal degradation mediated the enhanced anti-melanoma effects of TMZ with SJZT. RNA sequencing and experimental validation demonstrated that TMZ upregulated the bile salt transporter Slc10a1/Ntcp and downregulated detoxifying enzymes Ugt1a1 and Slco1b2/Oatp2, disrupting bile acid homeostasis. Notably, SJZT co-administration reversed these changes, restoring bile acid balance.
CONCLUSION: These findings reveal that SJZT can enhance TMZ's therapeutic efficacy while reducing hepatotoxicity, supporting its use as a promising adjuvant in melanoma treatment.